USE OF RIFABUTIN AND A COMBINATION OF RIFABUTIN AND ATOVAQUONE IN THE TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS - Patent 0794776

(19)

(11)

EP 0 794 776 A2

(12)

(43)	Date of publication:
	17.09.1997 Bulletin 1997/38

(21)	Application number: 95938501.0

(22)	Date of filing: 29.11.1995

(51)

International Patent Classification (IPC):

A61K 31/ 12^{( . )}
A61K 31/ 438^{( . )}
A61P 43/ 00^{( . )}

A61K 31/ 435^{( . )}
A61P 31/ 00^{( . )}

(86)	International application number:
	PCT/GB1995/002790

(87)	International publication number:
	WO 1996/016652 (06.06.1996 Gazette 1996/26)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	LT LV SI

(30)

Priority:

29.11.1994 GB 19940024013

(71)	Applicant: THE WELLCOME FOUNDATION LIMITED
	Greenford, Middlesex UB6 0NN (GB)

(72)	Inventor:
	COMLEY, John Charles William Beckenham, Kent BR3 3BS (GB)

(74)	Representative: Learoyd, Stephanie Anne, et al
	Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN Greenford, Middlesex UB6 0NN (GB)

(54)	USE OF RIFABUTIN AND A COMBINATION OF RIFABUTIN AND ATOVAQUONE IN THE TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS